Mcl-1 antagonists

US10040780B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10040780-B2
Application numberUS-201515123232-A
CountryUS
Kind codeB2
Filing dateMar 3, 2015
Priority dateMar 3, 2014
Publication dateAug 7, 2018
Grant dateAug 7, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Provided herein are Mcl-1 antagonist compositions and methods of treating g the compositions described herein.

First claim

Opening claim text (preview).

What is claimed is: 1. A compound having the formula: wherein, L 1 , L 2 , L 3 , L 4 , L 5 , and L 6 are independently a bond, —C(O)—, —C(O)O—, —C(O)NR 7 —, —O—, —S(O) n —, —S(O)NR 7 —, —C(O)NR 7 S(O) 2 —, —NR 7 —, substituted or unsubstituted alkylene, or substituted or unsubstituted heteroalkylene, substituted or unsubstituted cycloalkylene, substituted or unsubstituted heterocycloalkylene, substituted or unsubstituted arylene, or substituted or unsubstituted heteroarylene; R 7 is independently hydrogen, halogen, —N 3 , —NO 2 , —CF 3 , —CCl 3 , —CBr 3 , —CI 3 , —CN, —OH, —NH 2 , —COOH, —CONH 2 , —NO 2 , —SH, —SO 2 Cl, —SO 3 H, —SO 2 Ph, —SO 2 NH 2 , —NHNH 2 , —ONH 2 , —OCH 3 , —NHCNHNH 2 , substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl; n is 0, 1, or 2; R 1 is halogen, —N 3 , —CF 3 , —CCl 3 , —CBr 3 , —CI 3 , —CN, —CHO, ═O, —OR 1A , —NR 1B R 1C , —COOR 1A , —CONR 1B R 1C , —NO 2 , —SR 1D , —SO n1 R 1B , —S(O) n1 OR 1B , —S(O) n1 NR 1B R 1C , —NHNR 1B R 1C , —ONR 1B R 1C , —NHC(O)NHNR 1B R 1C , substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl, wherein R 1 and R 2 are optionally joined together to form a substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl; R 2 is hydrogen, halogen, —N 3 , —CF 3 , —CCl 3 , —CBr 3 , —CI 3 , —CN, —CHO, ═O, —OR 2A , —NR 2B R 2C , —COOR 2A , —CONR 2B R 2C , NO 2 , SR 2D , —SO n2 R 2B , —SO n2 OR 2B , —SO n2 NR 2B R 2C , —NHNR 2B R 2C , —ONR 2B R 2C , —NHC(O)NHNR 2B R 2C , substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl, wherein R 2 and R 3 are optionally joined together to form a substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl; R 3 is hydrogen, halogen, —N 3 , —CF 3 , —CCl 3 , —CBr 3 , —CI 3 , —CN, —CHO, ═O, —OR 3A , —NR 3B R 3C , —COOR 3A , —CONR 3B R 3C , NO 2 , SR 3D , —SO n3 R 3B , —SO n3 OR 3B , —SO n3 NR 3B R 3C , —NHNR 3B R 3C , —ONR 3B R 3C , —NHC(O)NHNR 3B R 3C , substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl, wherein R 3 and R 4 are optionally joined together to form a substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl; R 4 is hydrogen, halogen, —N 3 , —CF 3 , —CCl 3 , —CBr 3 , —CI 3 , —CN, —CHO, ═O, —OR 4A , —NR 4B R 4C , —COOR 4A , —CONR 4B R 4C , NO 2 , SR 4D , —SO n4 R 4B , —SO n4 OR 4B , —SO n4 NR 4B R 4C , —NHNR 4B R 4C , —ONR 4B R 4C , —NHC(O)NHNR 4B R 4C , substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl; R 5 is independently hydrogen, halogen, —N 3 , —CF 3 , —CCl 3 , —CBr 3 , —CI 3 , —CN, —CHO, ═O, —OR 5A , —NR 5B R 5C , —COOR 5A , —CONR 5B R 5C , NO 2 , SR 5D , —SO n5 R 5B , —SO n5 OR 5B , —SO n5 NR 5B R 5C , —NHNR 5B R 5C , —ONR 5B R 5C , —NHC(O)NHNR 5B R 5C , substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl, wherein R 5 and R 6 are optionally joined together to form a substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl; R 6 is hydrogen, halogen, —N 3 , —CF 3 , —CCl 3 , —CBr 3 , —CI 3 , —CN, —CHO, ═O, —OR 6A , —NR 6B R 6C , —COOR 6A , —CONR 6B R 6C , NO 2 , SR 6D , —SO n6 R 6B , —SO n6 OR 6B , —SO n6 NR 6B R 6C , —NHNR 6B R 6C , —ONR 6B R 6C , —NHC(O)NHNR 6B R 6C , substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl; R 1A , R 2A , R 3A , R 4A , R 5A , R 6A , R 1B , R 2B , R 3B , R 4B , R 5B , R 6B , R 1C , R 2C , R 3C , R 4C , R 5C , R 6C , R 1D R 2D , R 3D , R 4D , R 5D , and R 6D are independently hydrogen, substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl, wherein R 6B and R 6C , are optionally joined together to form a substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl; n1, n2, n3, n4, n5, and n6 are independently 1 or 2; and z is 1 or 2. 2. The compound of claim 1 , wherein L 1 is a bond, or —S(O) 2 —. 3. The compound of claim 2 , wherein L 2 and L 3 are independently a bond or substituted or unsubstituted alkylene. 4. The compound of claim 3 , wherein L 4 is a bond or S(O) 2 —. 5. The compound of claim 4 , wherein L 5 is a bond, —O—, or substituted or unsubstituted alkylene. 6. The compound of claim 5 , wherein L 6 is a bond or —C(O)—. 7. The compound of claim 6 , wherein R 4 is halogen, substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted aryl or joined together with R 3 to form a substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, or substituted or unsubstituted aryl. 8. The compound of claim 7 , wherein R 4 is R 11 -substituted or unsubstituted alkyl or R 11 -substituted or unsubstituted aryl, wherein R 11 is halogen, oxo, —OH, substituted or unsubstituted alkyl or substituted or unsubstituted aryl. 9. The compound of claim 8 , wherein R 2 is hydrogen, joined together with R 1 to form a substituted or unsubstituted cycloalkyl or substituted or unsubstituted heterocycloalkyl, or joined together with R 3 to form substituted or unsubstituted heterocycloalkyl or substituted or unsubstituted aryl. 10. The compound of claim 9 , wherein R 3 is hydrogen. 11. The compound of claim 1 having the formula: 12. The compound of claim 11 , wherein R 5 is —OR 5A , wherein R 5A is R 13 -substituted or unsubstituted alkyl, R 13 -substituted or unsubstituted heteroalkyl; R 13 is halogen —OH, ═O, —CF 3 , —NR 13A R 13B , substituted or unsubstituted alkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl; R 13A and R 13B are independently hydrogen or substituted or unsubstituted alkyl.

Assignees

Inventors

Classifications

  • containing three or more hetero rings · CPC title

  • directly linked by a ring-member-to-ring-member bond · CPC title

  • C07D405/04Primary

    directly linked by a ring-member-to-ring-member bond · CPC title

  • linked by a chain containing hetero atoms as chain links · CPC title

  • Ortho-condensed systems · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10040780B2 cover?
Provided herein are Mcl-1 antagonist compositions and methods of treating g the compositions described herein.
Who is the assignee on this patent?
Univ California, The Royal Institution For The Advancement Of Learning/Mcgill Univ, The Royal Institute For The Advancement Of Learning/Mcgill Univ
What technology area does this patent fall under?
Primary CPC classification C07D405/04. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Aug 07 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).